{"organizations": [], "uuid": "5aea5554ce0632fa39d428a90e5977080d4e13d2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180417.html", "section_title": "Archive News &amp; Video for Tuesday, 17 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shire-says-fda-approves-vonvendi-f/brief-shire-says-fda-approves-vonvendi-for-perioperative-management-of-bleeding-in-adult-patients-with-von-willebrand-disease-idUSASC09W4R", "country": "US", "domain_rank": 408, "title": "BRIEF-Shire Says FDA Approves Vonvendi For Perioperative Management Of Bleeding In Adult Patients With Von Willebrand Disease", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.579, "site_type": "news", "published": "2018-04-17T21:08:00.000+03:00", "replies_count": 0, "uuid": "5aea5554ce0632fa39d428a90e5977080d4e13d2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shire-says-fda-approves-vonvendi-f/brief-shire-says-fda-approves-vonvendi-for-perioperative-management-of-bleeding-in-adult-patients-with-von-willebrand-disease-idUSASC09W4R", "ord_in_thread": 0, "title": "BRIEF-Shire Says FDA Approves Vonvendi For Perioperative Management Of Bleeding In Adult Patients With Von Willebrand Disease", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "shire plc", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17 (Reuters) - Shire PLC:\n* FDA APPROVES VONVENDI FOR PERIOPERATIVE MANAGEMENT OF BLEEDING IN ADULT PATIENTS WITH VON WILLEBRAND DISEASE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-17T21:08:00.000+03:00", "crawled": "2018-04-18T18:11:42.004+03:00", "highlightTitle": ""}